Doctor’s Passport

Find your next topic

Explore the current textbook

Available drafts · Clinical review pending
Membership
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
Rapid

Metastatic spinal-cord compression

Essential points for quick revision.

Saved on this device
!
Cancer plus new cord or cauda equina dysfunction

New bladder or bowel dysfunction, gait difficulty, limb weakness, sensory loss, radicular pain or objective cord/cauda equina signs in a person with current or previous cancer is metastatic spinal cord compression until urgently assessed.

Action: Contact the MSCC coordinator immediately, treat as an oncological emergency, perform whole-spine MRI as soon as possible and within 24 hours, and give dexamethasone 16 mg orally or equivalent parenterally as soon as possible when neurological symptoms or signs are present, unless a specialist directs otherwise.

Synopsis

Recognise malignant spinal cord or cauda equina compression, distinguish neurological emergency from pain-only spinal metastasis, and start imaging, corticosteroid and definitive-treatment pathways within the NICE NG234 population.

  • MSCC in NICE NG234 means malignant compression of the spinal cord or cauda equina; it is not a label for every spinal metastasis or every episode of cancer-related back pain.
  • Cancer plus neurological symptoms or signs is an oncological emergency: contact the MSCC coordinator immediately and obtain whole-spine MRI as soon as possible, always within 24 hours.
  • Cancer plus suspicious spinal pain without cord symptoms still needs MSCC-service advice within 24 hours, but MRI is within 1 week rather than the emergency neurological pathway.

Key red flags

Current or previous cancer with new limb weakness, difficulty walking, sensory loss, radicular pain, bladder or bowel dysfunction, or cord/cauda equina signs.

Severe unremitting, progressive, mechanical or night spinal pain, pain aggravated by coughing or straining, local tenderness or claudication in a person with cancer.

Rapidly deteriorating neurology, respiratory compromise from a high lesion or loss of safe mobility requires emergency transfer and simultaneous spinal, oncology and anaesthetic input.

Movement-related pain or suspected instability raises fracture and mechanical-risk concerns; move with a documented plan and obtain early specialist stability advice.

Suspected radiological lymphoma or myeloma without neurological symptoms or signs needs haematology advice before corticosteroids because steroids can obscure diagnosis.

Fever, recent bacteraemia or immune compromise can indicate infection instead of, or alongside, malignancy; do not let a cancer history close the differential.

Cord dysfunction

Gait change, weakness, sensory level, hyperreflexia, extensor plantar responses and sphincter dysfunction imply myelopathy. Early lesions may present with pain and subtle walking difficulty before dense paralysis.

Cauda equina involvement

Radicular pain, lower-motor-neuron weakness, saddle sensory change and bladder/bowel dysfunction may reflect compression below the conus; treat malignant cauda equina compression within the MSCC emergency pathway.

Mechanical instability

Pain on standing or movement, deformity, collapse and load-related pain raise instability. Use a validated stability score only as part of specialist assessment, not as a substitute for examination and imaging.

Reasoning priorities

01
Whole-spine MRI

Identify all metastatic levels, epidural tumour and the degree of cord or cauda equina compromise.

For suspected MSCC, perform as soon as possible and within 24 hours. Include sagittal T1 and/or STIR, sagittal T2 and axial imaging through abnormalities. Pain-only suspected metastasis without MSCC uses the within-1-week route.

Worked reasoning

Worked case: walking is worseningKnown cancer with new gait weakness

A person with metastatic breast cancer develops progressive thoracic pain, leg weakness and difficulty walking.

  1. Treat this as suspected MSCC and an oncological emergency; contact the MSCC coordinator immediately while documenting the neurological and ambulatory baseline.
  2. Arrange whole-spine MRI locally as soon as possible and within 24 hours, using the specified sagittal sequences and axial imaging through abnormalities.
  3. Give dexamethasone 16 mg orally or equivalent parenterally as soon as possible because neurological symptoms are present; monitor glucose and provide proton-pump inhibition.
  4. Seek early spinal stability advice and use an individualised movement plan rather than automatically immobilising every patient in the same position.
  5. Coordinate surgery versus urgent radiotherapy through the spinal oncology team, incorporating compression, stability, tumour biology, prognosis, prior treatment and goals of care.

Key medicines

DexamethasoneGive 16 mg orally or equivalent parenterally as soon as possible, then 16 mg daily while awaiting surgery or radiotherapy.Monitor glucose, infection, mental state, gastrointestinal and proximal-muscle effects. Taper after surgery or from radiotherapy start under specialist guidance; stop if imaging rules out spinal metastases and MSCC. Pain-only metastasis and suspected lymphoma or myeloma have different rules.
Proton-pump inhibitorSelect the agent, route and dose from current local adult prescribing guidance.Review interactions, renal and hepatic context and ongoing need. Gastroprotection does not remove dexamethasone-related glucose, infection, psychiatric, myopathy or adrenal-suppression risks.
Open full textbook Answer 2 questions
Sources and review status3 sources · checked 13 Sept 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 13 Sept 2026; clinical approval remains outstanding.

  • NICE NG234 MSCC recommendationsPublished 6 September 2023; current recommendations body read 13 September 2026 for adults with spinal metastases or malignant cord/cauda compression, including referral, whole-spine MRI, immobilisation assessment, corticosteroids, biopsy, surgery and radiotherapy. It does not govern non-malignant CES, infection or haemorrhage.
  • NICE NG234 rationale and impactCurrent rationale body read 13 September 2026 for evidence limits behind imaging, corticosteroid and invasive-treatment recommendations, including low-sensitivity plain radiographs and biopsy-yield concerns. Used for reasoning, not as an independent protocol.
  • NICE NG234 evidence reviews2023 evidence-review collection checked 13 September 2026, especially imaging, immobilisation, corticosteroid and invasive-intervention domains. Population is malignant spinal disease; evidence gaps require individual multidisciplinary decisions.
Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom